Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir ‐ potential influence of censored observation

LINKED CONTENT This article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.17602 and https://doi.org/10.1111/apt.17788

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2024-01, Vol.59 (1), p.136-137
Hauptverfasser:	Tsai, Ying‐Nan, Wu, Jia‐Ling, Hsu, Yao‐Chun
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - therapeutic use DNA, Viral Hepatitis B e Antigens Hepatitis B surface antigen Hepatitis B Surface Antigens Hepatitis B virus - genetics Humans Incidence Tenofovir Tenofovir - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	LINKED CONTENT This article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.17602 and https://doi.org/10.1111/apt.17788
ISSN:	0269-2813 1365-2036 1365-2036
DOI:	10.1111/apt.17767